NauseaOlanzapineVomitingThe efficacy of olanzapine as an antiemetic agent in cancer chemotherapy has been demonstrated. However, few high-quality reports are available on the evaluation of olanzapine's efficacy and safety at a low dose of 5mg among patients treated with carboplatin regimens. Therefore,...
Smaller dosages (5 mg or 7.5 mg) can be given if these are more appropriate. Amaximum of 3 dosesmay be given if needed, 2 to 4 hours apart. Your doctor will monitor you for low blood pressure on standing (orthostatic hypotension) before giving you another dose. Tell your doctor if ...
Nausea 9 0 2 9 Somnolence 16 20 30 39 Tremor 3 0 5 7 Commonly Observed Adverse Reactions in Short-Term Trials of Oral Olanzapine as Adjunct to Lithium or Valproate In the bipolar I disorder (manic or mixed episodes) adjunct placebo-controlled trials, the most commonly observed adverse re...
Nausea or vomiting Dizziness, feeling lightheaded, or fainting Stomach cramps Joint pain Dark-colored pee Your skin or the whites of your eyes turning yellowish in color (also calledjaundice) Post-Injection Drowsiness (Zyprexa Relprevv).When long-acting olanzapine is injected into the muscle, it ma...
Dose Selection for Adjunctive Treatment When administered as adjunctive treatment to lithium or valproate, oral olanzapine dosing should generallybegin with 10 mg once-a-day without regard to meals. Antimanic efficacy was demonstrated in a dose range of 5 mg to 20 mg/day in clinical trials [see...
Olanzapine has five times the affinity for 5-HT2 receptors than D2 receptors and has been used to treat schizophrenia and delirium. Olanzapine's activity at multiple receptors, particularly at the D2, 5-HT2c, and 5-HT3 receptors which appear to be involved in nausea and emesis, has ...
For divalproex, nausea was more frequently observed. The average weight gain with olanzapine treatment was 2.5 kg, compared to 0.9 kg with divalproex treatment.The olanzapine treatment group had significantly greater mean improvement of mania ratings and a significantly greater proportion of patients ...
Zyprexa is indicated for adults and children older than 13 years. Although it helps manage behavioral symptoms, Zyprexa is not recommended for treatment of behavioral problems due to Alzheimer’s disease or dementia in older adults. It is sometimes used to prevent nausea and vomiting due to chemot...
nausea, vomiting, diarrhea, loss of coordination, very stiff (rigid) muscle, high fever, sweating, confusion, uneven heartbeats, tremors, headache, slurred speech, vomiting, severe weakness, feeling unsteady, shallow breathing, increased thirst, ...
It is suggested that patients with diabetes and those with high risk factors for diabetes should be properly monitored. The following acute symptoms, such as sweating, insomnia, tremor, anxiety, nausea or vomiting, are rarely found in patients with sudden withdrawal of ornithine (< 0 . ...